Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(450/week)
Manufacturing
(348/week)
Technology
(352/week)
Energy
(230/week)
Other Manufacturing
(292/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
REGENXBIO Inc.
Feb 16, 2021
REGENXBIO Announces Additional Positive Interim Phase I/IIa and Long-Term Follow-Up Data of RGX-314 for the Treatment of Wet AMD
Feb 08, 2021
REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at 17th Annual WORLDSymposium(TM) 2021
Feb 05, 2021
REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2021 Conference
Jan 08, 2021
REGENXBIO Announces Pricing Of Public Offering Of Common Stock
Jan 06, 2021
REGENXBIO Announces Proposed Public Offering Of Common Stock
Dec 10, 2020
REGENXBIO Announces Dosing of First Patient in Phase II ALTITUDE(TM) Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery
Dec 09, 2020
REGENXBIO Announces Positive Interim Data and Update for Phase I/II Trial of RGX-121 for the Treatment of MPS II
Dec 01, 2020
REGENXBIO Announces Dosing of First Patient in Phase I/II Trial of RGX-111 for the Treatment of Mucopolysaccharidosis Type I
Nov 23, 2020
REGENXBIO to Present at Upcoming Investor Conferences
Nov 10, 2020
REGENXBIO Announces Presentations at the American Academy of Ophthalmology 2020 Annual Meeting
Nov 05, 2020
REGENXBIO to Present at Upcoming Investor Conferences
Nov 04, 2020
REGENXBIO Reports Third Quarter 2020 Financial Results and Operational Highlights
Oct 27, 2020
REGENXBIO to Receive $80.0 Million Milestone Payment from Novartis AG
Sep 30, 2020
REGENXBIO Announces Continued Progress and Expansion of Clinical Development Program for RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II)
Sep 25, 2020
REGENXBIO to Participate in Upcoming Investor Conferences
Sep 09, 2020
REGENXBIO Announces Dosing of First Patient in Phase II AAVIATE(TM) Trial of RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery
Sep 02, 2020
REGENXBIO to Participate in Upcoming Investor Conferences
Aug 25, 2020
REGENXBIO Announces FDA Clearance of IND for Phase II Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery
Aug 04, 2020
REGENXBIO Announces Additional Positive Interim Phase I/IIa Trial Update and Program Updates for RGX-314 for the Treatment of Wet AMD
Jul 08, 2020
REGENXBIO Provides Update on Progress of Clinical Programs for Rare Genetic Neurodegenerative Diseases
Page 1
››
Latest News
Mar 29, 2024
Ford Motor Company Issues 2024 Proxy Statement, Announces May 9 as Date for Virtual Annual Meeting
Mar 29, 2024
Global Armored Vehicles Market Top Player Analysis: Strong Global Demand for Armored Vehicles geared towards...
Mar 29, 2024
Dubai Electricity and Water Authority PJSC Shareholders Approve Payment of AED 3.1 Billion in Dividends
Mar 29, 2024
Prevalon Energy Secures Contract with Idaho Power for New Integrated Battery Energy Storage System (BESS)
Mar 29, 2024
Spring Bengtzen and Utah Life Real Estate Group Partners with PLACE For Next Level Growth
Mar 29, 2024
Element Solutions Inc to Participate in an Electronics Q&A Session Hosted by Goldman Sachs
Mar 29, 2024
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend U. S. Steel Shareholders Vote “FOR”...
Mar 29, 2024
Elevate Your Sales Skills with BRS Roofing Supply's Exclusive Bootcamp Featuring Expert Taylor McCarthy
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events